Dyax Corp. to Participate in the 25th Annual ROTH Conference

Published: Mar 12, 2013

Dyax Corp. (NASDAQ: DYAX) announced today that the Company will participate in the 25th Annual ROTH Conference, being held March 17-20, 2013, at the Ritz-Carlton Laguna Niguel in Dana Point, CA. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Tuesday, March 19 at 5:30 PM (PT). Mr. Christensen will provide a corporate update regarding the Company’s key value drivers – KALBITOR® (ecallantide) and the angioedema portfolio, as well as the Licensing and Funded Research Program (LFRP).

Back to news